David Barbie
Company: Dana Faber cancer institute
Job title: Associate Director
Seminars:
Panel Discussion: To What Extent Will Ex-Vivo Platform Replace In-Vivo Models From Technical, Ethical, and Regulatory Standpoints? 11:20 am
day: Day Two
RNA-Sequencing Analysis of Immunotherapy Response in Organotypic Tumor Spheroids 12:00 pm
Bulk RNA-sequencing (RNA-seq) uncovers dynamic responses to interferon-gamma versus PD- 1blockade in murine organotypic spheroids Development of methods to extract cells and perform single cell RNAseq refines this analysis These high resolution ex vivo functional studies help to uncover novel immunobiologyRead more
day: Day Two